Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Mind Medicine Inc.

MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
From Mind Medicine Inc.
Via Business Wire
Tickers MNMD
MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)
From Mind Medicine Inc.
Via Business Wire
Tickers MNMD
MindMed Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy
From Mind Medicine Inc.
Via Business Wire
Tickers MNMD
MindMed Announces New Employee Inducement Grants
From Mind Medicine Inc.
Via Business Wire
Tickers MNMD
MindMed to Participate in Upcoming Investor Conferences
From Mind Medicine Inc.
Via Business Wire
Tickers MNMD
MindMed Reports Third Quarter 2024 Financial Results and Business Updates
From Mind Medicine Inc.
Via Business Wire
Tickers MNMD
MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update
From Mind Medicine Inc.
Via Business Wire
Tickers MNMD
MindMed Announces New Employee Inducement Grants
From Mind Medicine Inc.
Via Business Wire
Tickers MNMD
MindMed to Participate in September Investor Conferences
From Mind Medicine Inc.
Via Business Wire
Tickers MNMD
MindMed Reports Second Quarter 2024 Financial Results and Business Updates
From Mind Medicine Inc.
Via Business Wire
Tickers MNMD
MindMed to Present at Canaccord Genuity’s 44th Annual Growth Conference
From Mind Medicine Inc.
Via Business Wire
Tickers MNMD
MindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business Update
From Mind Medicine Inc.
Via Business Wire
Tickers MNMD
MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer
From Mind Medicine Inc.
Via Business Wire
Tickers MNMD
MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT)
From Mind Medicine Inc.
Via Business Wire
Tickers MNMD
MindMed to be Included in Russell 2000® and Russell 3000® Indexes
From Mind Medicine Inc.
Via Business Wire
Tickers MNMD
MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
From Mind Medicine Inc.
Via Business Wire
Tickers MNMD
MindMed to Participate in June Conferences
From Mind Medicine Inc.
Via Business Wire
Tickers MNMD
MindMed Completes Enrollment of Phase 2a Trial of MM-120 in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)
From Mind Medicine Inc.
Via Business Wire
Tickers MNMD
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.